1. IDENTIFICATION OF THE SUBSTANCE / PREPARATION AND THE COMPANY
Description: Transglutaminase, protein glutamine gamma glutamyltransferase
Manufacturer / Supplier: ShenYang Kinetika Biotec Co.,Ltd.
Address: Xing Nong Road27-2,Shenbei District, Shenyang,Liaoning,110164, P.R.CHINA
2. COMPOSITION / INFORMATION ON INGREDIENTS
KINEZYME TG is a powder type enzyme. Inappropriate handling may release dust. Inhalation of
enzyme dust or aerosols may induce sensitization and may cause allergic type reactions in
sensitized individuals. The preparation is irritating to eyes and skin.
Inhalation: Remove from exposure. If irritation or allergic response, occurs consult a doctor.
Eye contact: Rinse with plenty of water for at least 15 minutes. Should irritation occur, seek
Skin contact: Wash off with plenty of water.
Ingestion: Rinse mouth with plenty of water and throat thoroughly with water, then consult a
Suitable fire extinguishing media: Water, foam
Protection against fire and explosions: No special requirement
After spillage avoid raising of aerosols dust from dried preparation. Take up by mechanical means,
preferably by a vacuum equipped with a high efficiency filter. Flush remainder carefully with
plenty of water. Never use high pressure water jet. Provide for sufficient ventilation. Wash
Shenyang Kinetika Biotec Co., Ltd
Avoid formation of aerosols and dust from dried preparation. Provide for good ventilation of the
room, when handling this product. Store container in a dry and cool place.
8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Respiratory protection: Respirator approved for this type of aerosols & dust
Eye protection: Protecting glasses or eye shield
Appearance: White to light yellow powder
The preparation is stable under normal conditions of use
Inhalation: May cause sensitization by inhalation
Ingestion: Neither important effect nor critical hazard known
Skin contact: Neither important effect nor critical hazard known
Eye contact: Neither important effect nor critical hazard known
Chronic effects: Once sensitized, a strong allergic reaction may occur with a low exposure level.
Carcinogenicity: Neither important effect nor critical hazard known
Mutagen impact: Neither important effect nor critical hazard known
Teratogenicity: Neither important effect nor critical hazard known
Effects on development: Neither important effect nor critical hazard known
Effects on fertility: Neither important effect nor critical hazard known
The preparation is believed not to be dangerous to the environment with respect to mobility,
persistence and degradability, bioaccumulative potential, aquatic toxicity and other data relating to
Shenyang Kinetika Biotec Co., Ltd
No special disposal method required, except to be in accordance with current local authority
Risk phrase(s): R42 – May cause sensitization by inhalation
Safety phrases: S22 – do not breathe dust
S36/37 – Wear suitable protective clothing and gloves
The information contained in this material safety data sheet, as of the issue date, is believed to be
However, the accuracy or completeness of this information and any recommendations or
suggestions are made without warranty or guarantee. Since the conditions of use are beyond the
control of our company, it is the responsibility of the user to determine the conditions of safe use
of this product. The information in this sheet does not represent analytical specifications, for
which please refer to our technical data sheet.
Shenyang Kinetika Biotec Co., Ltd
CDC H1N1 Flu | What Should Pregnant Women Know About 2009 H1N1 Flu (Swine Fl. What Should Pregnant Women Know About 2009 H1N1 These questions and answers have been updated to include new information on 2009 H1N1 flu in pregnant women. Both seasonal and 2009 H1N1 flu viruses will circulate during the 2009-2010 flu season. A pregnant woman who thinks she has the flu should call her doctor right aw
September, 2006 Volume 6, No. 3 WHOLISTIC NEWS REVIEWS: TRADITIONAL, COMPLEMENTARY, ALTERNATIVE, AND PSYCHO- SOCIAL MODALITIES OF TREATMENT Larry Lachman, PsyD Blood pressure and insulin improved with transcendental meditation Maura Paul-Labrador, MPH and her colleagues at Cedars-Sinai Medical Center in Los Angeles report that in a study of 103 subjects with stable coronary